Abstract: Chinese clinical trials: chictr.org.cn, ChiCTR1900021017. Registred on 25/01/2019.
Introduction
Thoracoscopic surgery, or Video-Assisted Thoracoscopic Surgery (VATS), is a standard minimally invasive approach for pulmonary resections. Despite its advantages over open-chest surgery, patients still experience significant acute postoperative pain stemming from rib retraction and chest tube placement. Inadequate pain management can lead to "splinting"—a shallow breathing pattern that increases the risk of pneumonia and other pulmonary complications. While systemic opioids and epidurals are common, they carry risks of side effects and technical complications. This study evaluates ultrasound-guided intercostal nerve block (ICNB) as a safer, regional alternative for preemptive analgesia.
Methods
This single-center, randomized, double-blinded trial enrolled 126 patients aged 18–70 undergoing thoracoscopic pulmonary resection. Patients were randomized into two groups: the ICNB group, which received a preemptive block of the T3–T10 nerves using ropivacaine under ultrasound guidance, and a control group. Both groups had access to patient-controlled analgesia (PCA) with sufentanil for postoperative relief. Ultrasound guidance was utilized to ensure precise needle placement and minimize the risk of pneumothorax.
Results
The study found that ICNB significantly improved pain outcomes during the critical early recovery phase. Visual Analog Scale (VAS) scores were significantly lower in the ICNB group compared to the control group at 0, 4, 8, 16, 24, and 48 hours post-operation ($P < 0.001$ for early intervals).
Beyond pain scores, the ICNB group demonstrated superior clinical recovery metrics:
- Opioid Sparing: Only 9.8% of the ICNB group required rescue analgesia, compared to 31% in the control group ($P = 0.004$).
- Functional Recovery: The duration of chest tube insertion was significantly shorter in the ICNB group (4.69 days vs. 5.67 days, $P = 0.036$), suggesting that better pain control facilitates improved respiratory mechanics and faster healing.
Discussion
The findings suggest that preemptive ICNB effectively interrupts afferent pain signals before surgical trauma occurs, preventing central nervous system sensitization. The block is most effective during the first 48 hours, managing the acute peak of surgical pain. By reducing the need for rescue opioids, ICNB helps avoid common side effects like nausea and vomiting, while earlier chest tube removal indicates a smoother transition to functional recovery.
Limitations and Future Work
While the results are promising, the study focused on pain at rest; future research should evaluate pain during activity (e.g., coughing), which is more critical for preventing pulmonary complications. Additionally, the VAS remains a subjective measure. Future trials could incorporate objective biomarkers or continuous intercostal catheters to extend the analgesic effect beyond the initial 48-hour window.
Summary updated